Staff editor

The gut, conductor of our health. The International Yakult Symposium congress report  

A symphony of microbiome insights: from early infancy to advanced age, the microbiome orchestrates critical processes that affect our health.

Gut dysbiosis and cancer: new insights into immunotherapy resistance and patient survival

Microbiomepost discussed with Lisa Derosa, oncologist at Gustave Roussy Hospital in Paris, about the link between gut dysbiosis and cancer, shedding light on its role in immunotherapy resistance and patient…

Supporting women’s health through menopause: probiotic insights from IFF Health

Exploring probiotics for menopause with Maider Gutierrez, Business Development Lead for Women’s Health & Healthy Aging, IFF Health: solutions to support women's health and manage symptoms effectively.

Exploring the biotechnological potential of bacteriocinogenic lactic acid bacteria

Microbiomepost conducted an exclusive interview with Svetoslav Todorov, from Sao Paulo University in Brazil, about the benefits of certain lactic acid bacteria.

Health Canada Authorizes Functional Claim for SynbÆctive® Femme, a Patented Probiotic Formula for Women’s Health

The recently patented probiotic combination specifically focused on women’s urogenital health.

European microbiome leaders unite to accelerate global therapeutic development

The partnership aims to accelerate the development and approval of microbiome-based therapeutics by harmonizing regulatory frameworks.

Understanding regulatory pathways for microbial products in feed and food

Microbiomepost conducted an exclusive interview with Mireia Romagosa Vilarnau, Argenta Global, about the registration of microbial products.

Harnessing microbiome-based biomarkers: a multidisciplinary Delphi Consensus and EU’s new initiative

Delphi survey highlights promises and challenges in clinical use of microbiome-based biomarkers.

Unlocking the secrets of probiotic synergy: classic and Next-Gen interactions in the holobiont

‘We are trying to understand how Lactobacillus reuteri DSM 17938 is able to cross-feed and cross-talk to other bacteria’ - Gianfranco Grompone, scientific director at BioGaia.

New partnership aims to revolutionize rheumatoid arthritis treatment through metabolomics

Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study announce partnership to better understand the molecular mechanisms of rheumatoid arthritis.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top